Celon Pharma S.A. is a pioneering European biopharmaceutical company, primarily focused on the discovery and clinical-stage development of innovative therapies. With a deep commitment to addressing unmet medical needs, our mission is to transform the treatment landscape for patients suffering from neurological, metabolic, anti-inflammatory, and oncological diseases.
Our approach:
- Innovation with mRNA and bispecifics: utilizing sophisticated technologies like mRNA and bispecifics, we aim to develop novel therapies that can offer breakthrough solutions for difficult-to-treat conditions.
- Resource and capital efficiency: our development strategy is underpinned by a dual approach of generating revenue from established generic sales and securing substantial co-funding through non-refundable grants from the European Union. This model ensures efficient utilization of resources and capital in advancing our therapeutic candidates.
Address
WarsawPoland
